Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-27

FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Accord Healthcare, Inc. to market a generic combination of carbidopa and levodopa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (generic) (Carbidopa and Levodopa)

Snippet

SUPPL AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)